Purpose: This study assessed whether multisegmental disease that is severe enough to require an inflow procedure adversely affects infrainguinal bypass patency, limb salvage, or patient survival rates.
before or concurrent with the infrainguinal bypass graft. Although infrainguinal bypass patency rates from reconstructed inflow sources have been reported, 1-7 there are few data to suggest whether a reconstructed inflow source functions as well as a normal nonreconstructed inflow source with regard to inffainguinal bypass patency rates. In addition, the effect o f inflow reconstruction on infrainguinal bypass grafts with different materials is not clear. 1,3 Finally, because patients who have multisegmental disease have a greater incidence of disease progression, 8 it is not known whether, after correction of the inflow lesion, this progression will adversely affect infrainguinal bypass results. If it does affect results, how should these patients be managed?
The purpose of this study was to investigate whether multisegmental disease that is severe enough to require an inflow procedure adversely affects infrainguinal graft patency, patient limb salvage, or patient survival rates compared with those of patients who have only infrainguinal disease at the time of revascularization.
METHODS
The records of 495 patients who underwent primary infrainguinal revascularization procedures for arterial occlusive disease bctween 1990 and 1995 were reviewed. Preoperative risk factors, indications for operation, graft material, and the sites of the distal anastomosis were noted. The patients were divided into two groups. The "Inflow" group consisted of those patients who had reconstructed inflow before, or concurrent with, the primary infrainguinal revascularization procedure, whereas the "No inflow" group had normal nonreconstructed inflow. Saphenous vein and prosthetic bypass grafts were evaluated separately.
Inflow procedures were categorized as aortoiliofemoral bypass procedures, extraanatomic bypass procedures (femorofemoral and axillofemoral bypass procedures), balloon angioplasty with and without stent placement, and iliofemoral endarterectomy. The iliofemoral endarterectomy procedures performed were extensive endarterectomy procedures that required mobilization of the inguinal ligament and proximal clamping at the level of the common iliac artery. These procedures were performed when necessary to provide satisfactory inflow to the infrainguinal bypass graft that was required to treat the patient's condition. When the need for an inflow procedure was questioned after review of the angiogram, intraarterial pressure measurements were obtained cither in the angiography suitc or operating room. Systolic pressure gradients of at least 5 mm Hg across lesions, or mean pressure gradients of at least 10 mm Hg after papaverine administration, were considered significant. Attempts were made to place the proximal anastomosis of the infrainguinal bypass graft on autogcnous tissue.
Changes in anlde-brachial indexes, duplex ultrasound scans, and arteriograms were used after the operation to assess bypass graft patency. Grafts were considered patent if they met the criteria established by the Society for Vascular Surgery. 9 Saphenous vein grafts were surveyed with ankle-brachial indexes and duplex scans routinely at months 3, 6, and 12 and then yearly thereafter. Impending venous graft failure was indicated by recurrent clinical symptoms, changes in the ankle-brachial index of 0.15 below the postoperative index, and peal; systolic velocities of less than 40 cm/sec or greater than 150 cm/sec by duplex scan. Patients who had prosthetic bypass grafts were examined yearly. Noninvasive tests were performed sporadically on the basis of recurrent clinical symptoms or dj'minished pulses on physical examination.
Operative results were assessed using conventional life table analysis. Primary patency was defined as the length of time the graft remained patent without any intervention whatsoever. Assisted primary patency was defined as the length of time a graft remained patent allowing for interventions to rescue a failing but patent graft. Secondary patency was defined as the length of time the graft remained patent allowing for interventions to restore thromhosed grafts. For graft patency, the reporting interval of those individuals who died or were lost to follow-up stopped at the time their graft was last noted to be patent. Each cndpoint was tal;en as the middle of the period between which the graft was last documented open and when it was revised or clearly shown to be occluded. Hemodynamic failure did not end assisted primary patency or secondary patency as long as the graft itself was open at exploration.
Graft failure was defined as an event that ended either primary patency, assisted primary patency, or secondary patcncy. Causes of graft failure were grouped into five categories: inflow failure, outflow failure, graft failure, nonmechanical failure, and unknown. Inflow failure was defined as either failure of an inflow procedure or the development of a new inflow lesion. Outflow failure was defined as the development of a new outflow lesion that resulted in insufficient runoff. Graft failure was defined as stenoses at the proximal or distal anastomosis or in the body of the graft. Also included in this group was the development of arteriovenous fistulas. A label of nonmechanical failure was applied when a graft had failed, but the failure could not be attributed to an inflow, outflow, or graft lesion. In cases in which the cause of failure was unknown because no intervention was made on the graft, it was labeled as such.
All data were stored and analyzed on a Macintosh 7100/66AV computer (Apple Computer, Cupertino, Calif.). Statistical analysis was performed using StatView 4.02 (Abacus Concepts, Berkeley, Calif.). Life table estimates were compared using the logrank test. Data were also analyzed using a proportional hazards regression model. Standard error estimates performed by StatView 4.02 were by the method of Greenwood, and the authors calculated the standard error by the method ofPeto. Analysis of December 1997 variance and ×2 analysis, as appropriate, were used to assess differences between continuous and nominal variables. A p value less than 0.05 was considered to indicate a statistically significant difference.
RESULTS
A total of 551 primary infrainguinal revascularization procedures were reviewed. Adjunctive inflow procedures were performed in 70 of the 339 (21%) with saphenous vein grafts. These operations were performed either before (n = 27) or concurrent with (n = 43) the saphenous vein graft infrainguinal bypass procedure (Vein+Inflow; Table I ). No inflow procedure was required in the remaining 269 grafts (79%; Vein). The Vein+Inflow and Vein populations were similar with regard to age (68 + I years vs 68 + 1 years), number of in situ grafts (23% vs 26%), and sites of distal anastomoses (above-knee popliteal, 11% vs 19%; below-knee popliteal, 39% vs 33%; tibial, 50% vs 48%). Significant population differences were more current smokers (44% vs 30%; p = 0.02) and fewer operations for limb salvage (44% vs 77%; p = 0.05) in the Vein+Inflow group.
There were 212 prosthetic bypass grafts, of which 88 (42%) had a prior (n = 17) or concurrent (n = 71) inflow procedure (Prosthetic+Inflow), whereas 124 (58%) did not (Prosthetic). The Prosthetic+Inflow and Prosthetic populations were similar with regard to age (69 + 1 years vs 70 + 1 years), operations for limb salvage (56% vs 52%), and sites of distal anastomoses (above-knee popliteal, 88% vs 90%). Significant population differences were more men (66% vs 46%; p = 0.004), more current smokers (58% vs 40%; p = 0.01), more patients with pulmonary disease (17% vs 5%; p = 0.003), and more patients with hyperlipidemia (23% vs 11%; p = 0.03) in the Prosthetic+Inflow group.
Inflow procedures included 71 aortoiliofemoral bypass procedures (45%), 56 iliofemoral endarterectomy procedures (35%), 23 balloon angioplasty procedures (15%), and eight extraauatomic bypass procedures (5%). Forty-four inflow procedures (28%) were performed before, and 114 (72%) concurrent with, the infrainguinal bypass procedures. More aortoiliofemoral bypass procedures (p < 0.01) were performed before, whereas more iliofemoral endarterectomy procedures (p < 0.01) were performed concurrent with the infrainguinal bypass procedure. The type of the inflow procedures did not vary between the Vein+Inflow and Prosthetic+Inflow groups, but the Prosthetic + Inflow group had more inflow procedures performed concurrently than the Vein+Inflow group (61% vs 80%; p = 0.001).
The 4-year primary patency rates for saphenous vein iufrainguinal revascularization procedures were lower in Vein+Inflow group (41% vs 54%; p = 0.006) when compared with the vein grafts from normal inflow sources (Fig. 1 ). There were no differences in the assisted primary patency and secondary patency rates in vein grafts that arose from a reconstructed inflow source compared with those that arose from a nonreconstructed inflow source. The assisted primary patency rates and secondary patency rates in the Vein+Inflow and Vein groups at 4 years were similar (62% vs 74% [ Table II ] and 64% vs 77% [Table III ], respectively). In patients who had pros- thetic infrainguinal grafts, there were no differences at 4 years for primary patency rate (45% vs 55%; Table IV ), assisted primary patency rate (60% vs 60%; Table V) , or secondary patency rate (60 vs 61%) regardless of the inflow source (Fig. 2) . Patency rates were not affected by the site of distal anastomosis, the indication for surgery, the inflow procedure performed, nor the timing of the inflow procedure. In December 1997 bypass procedures performed with saphenous vein grafts, smoking did not affect patency rates. In those bypass procedures with a prosthetic graft, secondary patency rates were lower in smokers (40% vs 60%; p < 0.01) regardless of the inflow status. Patency rates did not differ significantly when stratified by the various inflow procedures performed, nor by the timing of the inflow procedure. When these stratifications were pcrformcd, howcvcr, thcrc wcrc not enough members in each group to allow for accurate statistical analysis.
The most common cause of infrainguinal graft failure in the Vein+Inflow group was inflow failure, which caused 17 of the 36 bypass failures (47%). Inflow failure was responsible for only 20 of the 83 infrainguinal bypass failures in the Vein group (24%; p < 0.05). The most common cause of failure in the Vein group, however, was graft failure, which was responsible for 27 of the 83 bypass failures (32%; Table VI ). The most common cause of failure in patients who had a prosthetic graft was inflow failure, regardless of whether a reconstructed inflow was needed. Inflow failurc was rcsponsiblc for 19 of the 41 infrainguinal bypass failures in the Prosthetic+Inflow group (46%) and 13 of the 38 bypass failures in thc Prosthetic group (34% ; Table VII) .
Complete inflow occlusion with continued infrainguinal bypass graft patency (pseudoocclusion) occurred in one patient in the Vein+Inflow group and in two patients in the Vein group. This phenomenon did not occur in the patients who had prosthetic infrainguinal bypass grafts.
Inflow failure occurred at a greater frequency in those infrainguinal bypass grafts that arose from a reconstructed inflow source regardless of graft type. In the Vein+Inflow group, 17 of the 70 bypass grafts had an inflow failure (24%), whereas in the Vein group only 20 of the 269 bypass grafts had an inflow failure (7%; p < 0.001). The frequency of graft failure, outflow failure, and nonmechanical failure were similar between the Vein+Inflow group and the Vein group. In the Prosthetic+Inflow group, I9 of the 88 bypass grafts had an inflow failure (22%), whereas in the Prosthetic group only 13 of the 124 bypass grafts failed as a result of inflow failure (10%; p < 0.05). The frequency of graft failure, outflow failure, and nonmechanical failure were similar in the Prosthetic+Inflow group compared with the Prosthetic group.
More impending graft failures were identified in patients who had saphenous vein grafts than in those with prosthetic grafts. Of the 1 i9 saphenous vein grafts that failed, 52 (44%) were identified before graft occlusion, whereas only 13 of the 79 failed prosthetic grafts (17%) were identified before graft occlusion. The revisions performed in hemodynamically compromised saphenous vein grafts to establish assisted primary patency were 17 inflow procedures, 18 patch angioplasty procedures at the proximal anastomosis, seven patch angioplasty procedures within the body o f the graft, three arteriovenous fistula ligations, two patch angioplasty procedures at the distal anastomosis, and five outflow procedures. The revisions of the 13 prosthetic grafts included six inflow procedures, four patch angioplasty procedures at the proximal anastomosis, two patch angioplasty procedures at the distal anastomosis, and one outflow procedure. Limb salvage and patient survival rates were unaffected by inflow status. Limb salvage rates for the Vein+Inflow and Vein groups at 4 years were 87% and 81%, respectively, and 4-year survival rates were 72% and 65%, respectively. Five-year limb salvage rates for Prosthetic+Inflow and Prosthetic grafts were 88% and 85%, respectively, and 5-year survival rates were 54% and 65%, respectively. The limb salvage rate was lower at 5 years in those patients whose vein grafts were operated on for salvage (75% vs 97%; p < 0.001) and in those with a tibial anastomosis (above-knee popliteal, 86%; below-knee popliteal, 86%; tibial, 79%; p = 0.04). The patient survival rate mirrored the limb salvage rate, and at 5 years it was lower in those patients who underwent operation for limb salvage (33% vs 89%; p < 0.0001) and in those patients with a more distal anastomosis (above-knee popliteal, 80%; below-knee popliteal, 57%; tibial, 35%; p < 0.002). In patients with prosthetic grafts, the limb salvage rate was lower at 5 years in those patients who underwent operation for salvage (75% vs 96; p < 0.001), as was the patient survival rate (42% vs 78%; p = 0.0001). In prosthetic grafts, limb salvage and patient survival rates were independent of the site o f the distal anastomosis.
D I S C U S S I O N
Patients who need infrainguinal bypass procedures often require both an inflow procedure and an infrainguinal bypass graft to adequately treat the ischemic symptoms. We attempted to assess whether those infrainguinal bypass grafts that arose from a reconstructed inflow source performed as well as those that arose from normal nonreconstructed inflow. Eidt al. 6 had better results, with 6-year patency rates of 87%, although their only inflow intervention was an iliofemoral endarterectomy. Our patency rates for saphenous vein grafts combined with an inflow procedure were similar to these. Actuarial survival analysis of our data revealed long-term patency rates, limb salvage rates, and patient survival rates were all unaffected by the need for an inflow procedure, providing that those patients with impending graft failure were identified and the graft corrected before thrombosis. The only difference identified within our groups was that the primary patency rate was lower in the Vein+Inflow group compared with the Vein group. This difference resolved with assisted primary patency. We attempted to explain this difference by examining the causes of failure within each group. In saphenous vein bypass grafts, more failures in those infrainguinal bypass grafts that arose from a reconstructed inflow source were caused by inflow failure than in those that arose from normal nonreconstructed inflow source. Inflow failure in the latter group, however, did represent the second-leading cause of failure. This difference was not apparent in the prosthetic bypass grafts, as the leading cause of failure in both of these groups was inflow failure.
Inflow failure occurred at a greater frequency in those patients whose bypass graft arose from a reconstructed inflow source compared with those whose bypass graft arose from a nonreconstructed inflow source. Inflow failure as a major cause of infrainguinal bypass failure is not a new idea. Several studies have reported progression of aortoiliac discasc in 13% to 42% of patients with inflow disease, s,l° The rate of disease progression appcars to be different between those who have multiscgmental discasc compared with those with unilcvcl discase and may suggest that there is a biologic difference between these two groups, n Ellenby et al. 4 demonstrated that 50% of the failurcs in a study of sequential femorofemoropopliteal bypass were a result of progression of inflow disease. This experience is not limited to those patients who have multisegmental disease. Charlesworth et al. 12 showed that patients who had no evidence of aortoiliac insufficiency by clinical examination and angiographic evaluation, but who had a decreased pulsatility index at the femoral artery, had lower patency rates in their femoropopliteal grafts than patients who had a normal pulsatility index. Ouriel et al.,13 however, found that after thrombolysis most graft thromboses were caused by graft failures (proximal and distal anastomosis and graft body) and that only 4% to 7% ofinfrainguinal bypass failures were caused by inflow failure. This difference may be explained by the fact that the group of patients who underwent successful thrombolysis represents a subpopulation of patients encompassed in our larger group. Few patients in this current series underwent successful thrombolysis. This is demonstrated through the fact that the assisted primary patency rates and secondary patency rates were not different. Because of this small number of patients who underwent successful thrombolysis, analysis of the causes of failure in this subpopulation is not possible. In this report, inflow failure appears to play a major role in inftainguinal bypass graft failure. These failures are more readily identified before graft occlusion in the saphenous vein bypass group be-December 1997 cause those patients undergo intense graft surveillance, which will herald impending graft failure and further investigation to identify its source. This is not so in the prosthetic grafts, in which most inflow failures are identified after graft occlusion. Because inflow failure is a major cause ofinfrainguinal bypass occlusion, an argument can be made for intense patient surveillance to detect these inflow lesions before graft occlusion. This may be particularly important in patients who have multisegmental disease because they may have a more accelerated progression of their disease. Although the calculation of the true incidence of progression of inflow disease is not possible in these groups as a result of statistical limitations, there is a greater proportion of patients with multisegmental disease in whom progression of this disease develops and leads to infrainguinal graft failure.
Unlike saphenous vein grafts, routine monitoring with anlde-brachial indexes and duplex ultrasound is not currently accepted as effective in the surveillance of prosthetic bypass grafts. Assessing and monitoring patients for inflow disease is also a difficult task; however, duplex ultrasound is showing promise in evaluating aortoiliac stenosis. Recent reports have described sensitivities between 81% and 100% and specificities between 58% and 95% in detecting aortoiliac disease, depending on the degree of stenosis? 4-17 For patients who have multisegmental disease, surveillance through history, physical examination, and segmental pressures augmented with duplex ultrasound may be indicated to detect progression of inflow disease. Correction of this progression may prevent infrainguinal graft failure. Patients who have prosthetic infrainguinal bypass grafts and multisegmental disease may benefit most from this approach because they do not currently receive routine graft surveillance that would identify impending graft failure.
DISCUSSION
Dr. Frank J. Veith (Bronx, N.Y.). This is an interesting, well-written, and well-presented paper. It is important for several reasons.
First, it challenges the generally accepted notion that almost all infrainguinal graft failures are caused by anastomotic intimal hyperplasia or vein graft stenoses. We noted the importance of inflow problems when Dr. Luis Sanchez presented various aspects of our work on failing inftainguinal polytetrafluoroethylene (PTFE) and vein grafts to this Society in 1991 and 1993 (J Vasc Surg 1991;14:729-38 and 1993;18:981-90). In these articles, we observed that inflow and outflow lesions were more important causes of failure with both vein and prosthetic grafts than most people realized. Today's paper by Dr. Eagleton and his colleagues certainly supports our now-old but unrecognized observations about the importance of inflow disease as a cause of failure of both vein and PTFE grafts. Their work also supports our 1993 recommendation that surveillance is indeed justified with PTFE infrainguinal bypass grafts just as it is with vein bypass grafts.
I have some other comments and related questions. Although the authors used preoperative and intraoperative pressure measurements with papaverine to detect inflow stenoses, they may have still missed some. As we showed in 1990 (J Vase Surg 1990;12:78-83), some inflow stenoses that are quite significant hemodynamically can be missed unless femoral pressure measurements are made after flow is established in the infrainguinal bypass graft. Did the authors make such pressure measurements after establishing flow in the bypass graft?
My second comment is that with such measurements and C-arm fluoroscopy in the operating room, it is possible to localize and treat these unrecognized inflow stenoses at the time of the inftainguinal bypass procedure. Hopefully, this will decrease the incidence of failure as a result of inflow lesions. Do the authors agree with this?
Finally, do the authors believe that many of their inflow operations will be replaced with stenting procedures for iliac disease? And if so, do they think this will decrease or increase the number of failures caused by inflow problems? I worry that it will increase these problems.
Dr. Matthew J. Eagleton. Thank you, Dr. Veith. We certainly would agree that some hemodynamically significant inflow stenoses can be missed unless femoral artery pressure measurements are obtained after flow has been established by the infrainguinal bypass graft. We frequently measure femoral artery pressures after completion of the infrainguinal bypass, but this is not done on a routine basis.
When these inflow lesions are identified during the operation, we correct these lesions at the time of the infrainguinal bypass procedure. In fact, 61% of the inflow procedures performed on saphenous vein grafts and 81% of those performed on prosthetic grafts were done at the time of the infrainguinal bypass procedure. In several cases, the need for an inflow procedure was not apparent until after the infrainguinal bypass procedure had been performed.
In this series, 15% of the inflow procedures performed were iliac artery balloon angioplasty, and fewer than half of these had stents placed. I think that we will see an increase in the number of stenting procedures performed to treat iliac artery inflow disease. I am not sure whether the use of more stenting procedures will result in further inflow problems. From the data presented here, the number of patients who underwent a stenting procedure was too small to make an adequate analysis.
Dr. Keith D. Calligaro (Philadelphia~ Pa.). Currently, I think the position most vascular surgeons ~take is not to perform routine surveillance of prosthetic grafts. However, we find it helpful and useful to perform routine duplex ultrasound scans for prosthetic grafts as we do for vein grafts. We would agree with one of your conclusions, that prosthetic grafts possibly should be entered into the same type of a protocol. And I rise to echo what Dr. Veith said, that this may be a worthwhile intervention. When we did it, we found that many of the lesions were at the anastomosis, which could be repaired with a patch or jump graft. If there were low velocities throughout the graf L we would then get an arteriogram to identify inflow and outflow lesions.
Dr. Eagleton. We agree with your comments. Our analysis shows that in prosthetic grafts infloW failure and stenoses at the anastomotic sites account for a large percentage of our graft failures. By using routine surveillance, these lesions may be detected and corrected, as you have stated. We plan to change the way we currently evaluate our patients with prosthetic grafts, surveying them on a more frequent and routine basis.
Dr. Enrico Ascher (Brooklyn, N.Y.). I rise to congratulate you on your very nicely presented paper. I, however, disagree with the recommendation of doing more PTFE surveillance on a routine basis. We have done this for 4 years, and we have been disappointed because we have not found any specific parameter that can help us define or differentiate the failing from the nonfailing graft. We have had grafts that had less than 40 cm/sec of velocity that are widely patent for more than 4 years. We have had other ones that had excellent flow velocities with no lesions that failed all of a sudden. I am disappointed, unfortunately, to say that in our hands the graft surveillance for PTFE has not been rewarding. However, when we pick up those grafts when they're failing, then the results are excellent, as Dr. Veith said. We had an 82% patency rate at 3.5 years when we picked up a failing PTFE graft. But unfortunately, we're not able to pick those up in more than 20% of our cases.
Dr. Eagleton. What we would recommend may go beyond just surveying the graft itself, but actually performing routine patient surveillance. Many of our infrainguinal bypass graft failures were a result of failure in the inflow December 1997 tract. This accounted for a large percentage of our prosthetic graft failures and occurred at a high frequency in patients with known multisegmental disease. By surveying these patients' aortoiliac system we may detect disease progression and intervene before failure. The recent literature on using duplex ultrasound to evaluate the aortoiliac system ~uggests that we are improving in our ability to adequately identify and grade stenoses in this region. This method may prove useful for routine patient surveillance after infrainguinal bypass procedures.
Dr. Carl E. Bredenberg (Portland, Me.). When percutaneous transluminal angioplasty (PTA) first came out and was advocated as an inflow procedure before a distal reconstruction, some of us were concerned that its durability, while acceptable as an isolated procedure, might not be sufficient to base a distal reconstruction on. With return of symptoms after an isolated PTA procedure, one could always redo the PTA. We were concerned that PTA was somewhat less durable than surgical reconsn-uction and that failure of PTA in the presence of a distal reconstruction would compromise the patency of that distal reconstruction. We therefore at that time had a certain reluctance to use PTA to open an inflow artery that was going to supply a distal bypass graft. Because you have emphasized in your presentation how important recurrent or progressive inflow disease is as a cause of failure of infrainguinal reconstructions, can you give us any insights as to whether we should continue to use PTA for a proximal iliac lesion when we are also planning a distal reconstruction, or should we be more aggressive at surgical reconstruction of the aortoiliac disease if we are planning also to perform an infrainguinal reconstruction?
Dr. Eagleton. I believe that we would be fairly aggressive about performing redo angioplasty on a recurrent lesion. The second angioplasty procedure may be augmented by the placement of a stent. We base our decision to perform a more aggressive surgical procedure on where the lesion is located, the extent of the lesion, the presence ofmultifocal lesions, and the concern for the patency of the infrainguinal bypass graft.
We were not able to statistically show any difference in the infrainguinal bypass patency rates in those patients who underwent PTA compared with those who underwent an aortoiliofemoral bypass procedure or an iliofemoral endarterectomy. The number of patients in each of these groups was too small to make an adequate comparison.
Dr. Kumar R. Patel (Glen Ridge, N.J.). We are very particular about surveillance of our vein grafts, as well. But the one question we have not been able to answer to our satisfaction is, when you see a vein graft 6 months later and there is an increase in the peak systolic velocity, what velocity is significant? You mentioned 150 cm/sec. We have watched some patients who had velocities of 250 cm/sec, 300 cm/sec, and we don't know the answer. Can you tell us your basis for picldng 150 cm/sec? Dr. Eagleton. The criteria to which we apply significance in surveying our infrainguinal bypass grafts is based on studies previously published by Dr. Green and our group. The decision to perform a graft revision is rarely made only on the peak systolic velocity. Instead, we use a combination of recurrent clinical symptoms, a change in ankle-brachial index, and the peak systolic velocities.
Dr. Patel. I'm sure you have seen some patients who have just the increased frequency, with no symptoms and a normal ABI. We have seen some patients like that. What would you do? Would you go to angiography, or would you just continue to watch?
Dr. Eagleton. We would observe those patients for recurrent symptoms, changes in ABI, or further increases in the peak systolic frequencies.
Dr. Robert P. Leather (Albany, N.Y.). I have one question or clarification. It has been our experience that inflow occlusion does not necessarily result in the failure of an infraingninal vein bypass graft, particularly if it has access to collateral flow. Invariably, those bypass grafts survive that event. Now, it sounds like you've arbitrarily classified the vein bypass graft as a failure if there was inflow occlusion; is that correct?
Dr. Eagleton. The vein grafts were only classified as failures if they met our criteria for failure, such as recurrent clinical symptoms, changes in ankle-brachial index, and altered peak systolic velocities, but not on the patency of the inflow. As you observed, there were instances in which the inflow failed but the infrainguinal bypasses remained patent. Whether these grafts will eventually fail, I am not certain.
Dr. Leather. This is obviously in contrast to inflow failure above a synthetic graft, in which it is more than likely to result in failure.
I would also like to reemphasize the importance of the pressure after the bypass graft is placed. With the increase in flow, a stenotic area that was not critical before then becomes critical, and the resting flow rates, even with the use of vasodilators, are so low that the degree of stenosis has to be >70% diameter to show up on a pressure measurement.
Dr. Eagleton. Again, we use intraarterial pressure measurements after infrainguinal bypass procedures frequently, but not on a routine basis.
Dr. Richard M. Green. I just wanted to make a comment and address Dr. Ascher's comment, which we would agree with. We have had the chance to follow-up in a different study 250 patients who underwent above-lmee femoropopliteal bypass grafting with a prosthesis and to look at the behavior of these grafts with duplex scanning. There is no question that graft velocities in these grafts range from 30 to 150 cm/sec, and there is no predictive value to the graft velocity. So Dr. Ascher, I agree with you 100%. But what we're trying to say here is that there are other causes of graft failure and that those are things that perhaps duplex scanning can pick up. So I don't think we're in any disagreement here. I think the rules are going to be different with vein grafts than prosthetic grafts.
